<document>
 <type>
  6-K
  <sequence>
   1
   <filename>
    ea131129-6k_nanodimension.htm
    <description>
     REPORT OF FOREIGN PRIVATE ISSUER
     <text>
      <html>
       <head>
        <title>
        </title>
       </head>
       <body style="font: 10pt Times New Roman, Times, Serif">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <!-- Field: Rule-Page -->
        <div style="margin-top: 0; margin-bottom: 0; width: 100%">
         <div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">
         </div>
        </div>
        <!-- Field: /Rule-Page -->
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         SECURITIES AND EXCHANGE COMMISSION
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         Washington, D.C. 20549
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         Form 6-K
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         Report of Foreign Private Issuer
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         Pursuant to Rule 13a-16 or 15d-16
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         under the Securities Exchange Act of 1934
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         For the month of: December 2020 (Report
No. 2)
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         Commission file number: 001-37600
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         <u>
          NANO DIMENSION LTD.
         </u>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         (Translation of registrant’s name
into English)
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         2 Ilan Ramon
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         <u>
          Ness Ziona 7403635 Israel
         </u>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         (Address of principal executive offices)
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         Form 20-F ☒         Form
40-F ☐
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
        <!-- Field: Rule-Page -->
        <div style="margin-top: 0; margin-bottom: 0; width: 100%">
         <div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">
         </div>
        </div>
        <!-- Field: /Rule-Page -->
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
        <!-- Field: Page; Sequence: 1 -->
        <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
         <p style="margin: 0pt">
         </p>
        </div>
        <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">
         <p style="margin: 0pt">
         </p>
        </div>
        <!-- Field: /Page -->
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         <b>
          <u>
           CONTENTS
          </u>
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <b>
          Pricing of Registered Direct Offering
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         <b>
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         On December 6, 2020,
Nano Dimension Ltd. (the “
         <u>
          Company
         </u>
         ”) entered into definitive securities purchase agreements (each, a “
         <u>
          Purchase
Agreement
         </u>
         ”) with institutional investors to purchase an aggregate of 30,000,000 of the Company’s American Depositary
Shares (“
         <u>
          ADSs
         </u>
         ”), representing an equal number of the Company’s ordinary shares, par value NIS 5.00 per
share, at a purchase price of $6.00 per ADS in a registered direct offering (the “
         <u>
          Registered Direct Offering
         </u>
         ”).
The gross proceeds to the Company from the Registered Direct Offering will total $180 million. The closing of the
sale of the ADSs is expected to occur on or about December 9, 2020, subject to the satisfaction of customary closing conditions.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         Pursuant to the Purchase
Agreements, the Company has agreed not to issue, enter into any agreement to issue or announce the issuance or proposed issuance
of any ADSs, ordinary shares or ordinary share equivalents, or file any registration statement or any amendment or supplement thereto,
for a period of 30 days following the closing of the Registered Direct Offering, subject to certain customary exceptions.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         The Company also entered
into an agreement (the “
         <u>
          Placement Agency Agreement
         </u>
         ”) with ThinkEquity, a division of Fordham Financial Management,
Inc., as sole placement agent, or the Placement Agent, dated December 6, 2020, pursuant to which the Placement Agent agreed to
serve as the placement agent for the Company in connection with the Registered Direct Offering. The Company agreed to pay the Placement
Agent a cash placement fee equal to 4% of the gross proceeds received for the ADSs. In addition, pursuant to the Placement Agency
Agreement, the Company agreed to issue to the Placement Agent or its designees warrants to purchase up to a total of 5.0% of the
aggregate number of ADSs sold in the Registered Direct Offering (the “
         <u>
          Placement Agent Warrants
         </u>
         ”). The Placement
Agent Warrants shall be exercisable, in whole or in part, commencing on a date which is 180 days after the date of the Placement
Agency Agreement and expiring on the three and one-half year anniversary thereof at an initial exercise price per ADS of $7.50,
which is equal to 125% of the purchase price of the ADSs under the Purchase Agreements.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         The ADSs to be issued
in the Registered Direct Offering will be issued pursuant to a prospectus supplement, which will be filed with the Securities and
Exchange Commission (the “
         <u>
          SEC
         </u>
         ”), in connection with a takedown from the Company’s shelf registration statement
on Form F-3 (File No. 333- 251155).
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         The Company’s
press release containing additional details of the Registered Direct Offering is filed as Exhibit 99.1 hereto. Copies of the form
of Purchase Agreement, the Placement Agency Agreement and the Placement Agent Warrant are filed as Exhibits 10.1, 10.1.A and 10.1.B,
respectively, to this Report on Form 6-K and are incorporated by reference herein. The foregoing summaries of such documents are
subject to, and qualified in their entirety by reference to, such exhibits. A copy of the opinion of Sullivan &amp; Worcester Tel-Aviv
(Har-Even &amp; Co.) relating to the legality of the issuance and sale of the ordinary shares underlying the ADSs is attached as
Exhibit 5.1 hereto.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         This Report on Form
6-K shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of ADSs in any jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of
any such jurisdiction.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         This Report on Form
6-K is incorporated by reference into the registration statements on Form F-3 (File No.
         <a href="http://www.sec.gov/Archives/edgar/data/1643303/000121390019018682/ff32019_nanodimension.htm">
          333-233905
         </a>
         and
         <a href="http://www.sec.gov/Archives/edgar/data/1643303/000121390020041113/ea131059-f3asr_nanodimension.htm">
          333-251155
         </a>
         )
and Form S-8 (File No.
         <a href="http://www.sec.gov/Archives/edgar/data/1643303/000121390016018136/fs82016_nanodimensionltd.htm">
          333-214520
         </a>
         and
         <a href="http://www.sec.gov/Archives/edgar/data/1643303/000121390020023796/ea126024-s8_nanodimension.htm">
          333-248419
         </a>
         )
of the Company, filed with the SEC, to be a part thereof from the date on which this report is submitted, to the extent not superseded
by documents or reports subsequently filed or furnished.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
        </p>
        <!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
        <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt">
         <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
          <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
          1
          <!-- Field: /Sequence -->
         </p>
        </div>
        <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">
         <p style="margin: 0pt">
         </p>
        </div>
        <!-- Field: /Page -->
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         <b>
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <b>
          <u>
           Forward Looking Statements
          </u>
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">
         This Report on Form
6-K contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995 and other Federal securities laws.  Words such as “expects,” “anticipates,”
“intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions
or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking
statements in this report when it discusses expected timing of the closing of the Registered Direct Offering. Because such statements
deal with future events and are based on the Company’s current expectations, they are subject to various risks and uncertainties.
Actual results, performance or achievements of the Company could differ materially from those described in or implied by the statements
in this report. The forward-looking statements contained or implied in this report are subject to other risks and uncertainties,
including market conditions and the satisfaction of all conditions to, and the closing of, the Registered Direct Offering, as well
as those discussed under the heading “Risk Factors” in the Company’s annual report on Form 20-F filed with the
SEC on March 10, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, the Company undertakes
no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the
date hereof or to reflect the occurrence of unanticipated events.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          Exhibits
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
         Attached hereto and
incorporated herein are the following exhibits:
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">
         <b>
         </b>
        </p>
        <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
         <tr style="background-color: white">
          <td style="vertical-align: top; width: 10%; border-bottom: black 1.5pt solid">
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            <b>
             Exhibit No.
            </b>
           </font>
          </td>
          <td style="vertical-align: top; width: 1%">
          </td>
          <td style="vertical-align: bottom; width: 89%; border-bottom: black 1.5pt solid">
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            <b>
             Description
            </b>
           </font>
          </td>
         </tr>
         <tr style="vertical-align: top; background-color: rgb(204,238,255)">
          <td>
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            5.1
           </font>
          </td>
          <td>
          </td>
          <td style="text-align: justify">
           <a href="ea131129ex5-1_nanodimension.htm">
            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
             Opinion of Sullivan &amp; Worcester Tel-Aviv (Har-Even &amp; Co.)
            </font>
           </a>
          </td>
         </tr>
         <tr style="background-color: White">
          <td style="vertical-align: top">
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            10.1
           </font>
          </td>
          <td>
          </td>
          <td style="text-align: justify">
           <a href="ea131129ex10-1_nanodimension.htm">
            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
             Placement Agency Agreement dated December 6, 2020.
            </font>
           </a>
          </td>
         </tr>
         <tr style="background-color: rgb(204,238,255)">
          <td style="vertical-align: top">
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            10.1.A
           </font>
          </td>
          <td>
          </td>
          <td style="text-align: justify">
           <a href="ea131129ex10-1_nanodimension.htm#ex_a">
            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
             Exhibit A to Placement Agency Agreement - Form of Securities Purchase Agreement.
            </font>
           </a>
          </td>
         </tr>
         <tr style="background-color: White">
          <td style="vertical-align: top">
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            10.1.B
           </font>
          </td>
          <td>
          </td>
          <td style="text-align: justify">
           <a href="ea131129ex10-1_nanodimension.htm#ex_b">
            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
             Exhibit B to Placement Agency Agreement - Form of Placement Agent’s Warrant Agreement.
            </font>
           </a>
          </td>
         </tr>
         <tr style="background-color: rgb(204,238,255)">
          <td style="vertical-align: top">
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            23.1
           </font>
          </td>
          <td>
          </td>
          <td style="text-align: justify">
           <a href="ea131129ex5-1_nanodimension.htm">
            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
             Consent of Sullivan &amp; Worcester Tel-Aviv (Har-Even &amp; Co.) (included in Exhibit 5.1).
            </font>
           </a>
          </td>
         </tr>
         <tr style="vertical-align: top; background-color: White">
          <td>
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            99.1
           </font>
          </td>
          <td>
          </td>
          <td style="text-align: justify">
           <a href="ea131129ex99-1_nanodimension.htm">
            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
             Press Release issued by Nano Dimension Ltd. on December 6, 2020, titled “Nano Dimension Prices $180 Million Registered Direct Offering.”
            </font>
           </a>
          </td>
         </tr>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
        <!-- Field: Page; Sequence: 3; Value: 1 -->
        <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
         <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
          <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
          2
          <!-- Field: /Sequence -->
         </p>
        </div>
        <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">
         <p style="margin: 0pt">
         </p>
        </div>
        <!-- Field: /Page -->
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         <b>
          <u>
           SIGNATURES
          </u>
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
        </p>
        <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
         <tr style="vertical-align: top">
          <td>
          </td>
          <td colspan="2">
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            <b>
             <u>
              Nano Dimension Ltd.
             </u>
            </b>
           </font>
          </td>
         </tr>
         <tr style="vertical-align: top">
          <td>
          </td>
          <td colspan="2">
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            (Registrant)
           </font>
          </td>
         </tr>
         <tr style="vertical-align: top">
          <td style="width: 60%">
          </td>
          <td style="width: 5%">
          </td>
          <td style="width: 35%">
          </td>
         </tr>
         <tr style="vertical-align: top">
          <td>
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            Date: December 7, 2020
           </font>
          </td>
          <td>
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            By:
           </font>
          </td>
          <td style="border-bottom: black 1.5pt solid">
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            /s/ Yael Sandler
           </font>
          </td>
         </tr>
         <tr style="vertical-align: top">
          <td>
          </td>
          <td>
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            Name:
           </font>
          </td>
          <td>
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            Yael Sandler
           </font>
          </td>
         </tr>
         <tr style="vertical-align: top">
          <td>
          </td>
          <td>
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            Title:
           </font>
          </td>
          <td>
           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
            Chief Financial Officer
           </font>
          </td>
         </tr>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
         3
        </p>
        <!-- Field: Rule-Page -->
        <div style="margin-top: 0; margin-bottom: 0; width: 100%">
         <div style="font-size: 1pt; border-top: Black 1.5pt solid">
         </div>
        </div>
        <!-- Field: /Rule-Page -->
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
        </p>
       </body>
      </html>
     </text>
    </description>
   </filename>
  </sequence>
 </type>
</document>
